Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003466192 | SCV004193953 | likely pathogenic | Pyruvate dehydrogenase E3 deficiency | 2023-10-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003466192 | SCV004524512 | pathogenic | Pyruvate dehydrogenase E3 deficiency | 2023-09-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser28Phefs*14) in the DLD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DLD are known to be pathogenic (PMID: 8968745, 9934985). This variant is present in population databases (rs764704217, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with DLD-related conditions. For these reasons, this variant has been classified as Pathogenic. |